Gables Capital Management’s BELLUS Health Inc. BLU Stock Holding History

Gables Capital Management’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-134	Closed	-$965	–	389
2023 Q1	$965	Hold	134	–	–	﹤0.01%	361
2022 Q4	$1.1K	Hold	134	–	–	﹤0.01%	344
2022 Q3	$1K	Hold	134	–	–	﹤0.01%	336
2022 Q2	$1K	Hold	134	–	–	﹤0.01%	347
2022 Q1	$1K	Hold	134	–	–	﹤0.01%	344
2021 Q4	$1K	Hold	134	–	–	﹤0.01%	343
2021 Q3	$1K	Hold	134	–	–	﹤0.01%	348
2021 Q2	$0	Hold	134	–	–	﹤0.01%	384
2021 Q1	$1K	Hold	134	–	–	﹤0.01%	376
2020 Q4	$0	Hold	134	–	–	﹤0.01%	373
2020 Q3	$0	Hold	134	–	–	﹤0.01%	375
2020 Q2	$1K	Hold	134	–	–	﹤0.01%	353
2020 Q1	$1K	Hold	134	–	–	﹤0.01%	406
2019 Q4	$1K	Hold	134	–	–	﹤0.01%	342
2019 Q3	$1K	Buy	+134	New	+$945	﹤0.01%	347

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Gables Capital Management's BLU Position: Q2 2023 in Review

Gables Capital Management sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 134 shares — an estimated $965 sold.

Gables Capital Management first reported a position in BLU in Q3 2019 and held it in 15 quarters. The position peaked at $1.1K in Q4 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Gables Capital Management reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Gables Capital Management sold 134 BELLUS Health Inc. shares in Q2 2023, an estimated $965.
Gables Capital Management first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 15 quarters.
Gables Capital Management's BELLUS Health Inc. position peaked at $1.1K in Q4 2022.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Gables Capital Management's 13F filing for Q2 2023, filed 3 Aug 2023.